Dietary trans fats enhance doxorubicin-induced cardiotoxicity in mice

Journal of Food Science

Volumn 78, Issue 10, 2013, Pages

  Mong, Mei chin ^a   Hsia, Te chun ^b   Yin, Mei chin ^a,b  

^a ASIA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cardiac injury; Coagulation; Doxorubicin; MAPK; NF B; Trans fat

Indexed keywords

MUS;

ANTITHROMBIN III; C REACTIVE PROTEIN; CARDIOTOXIN; CCL2 PROTEIN, MOUSE; CREATINE KINASE; DOXORUBICIN; FIBRINOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; REACTIVE OXYGEN METABOLITE; TRANS FATTY ACID; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COAGULATION; DRUG ANTAGONISM; DRUG POTENTIATION; FAT INTAKE; GENETICS; HEART DISEASE; HEART INJURY; MALE; MAPK; METABOLISM; MOUSE; NF-ΚB; PATHOLOGY; TRANS FAT; UPREGULATION;

CARDIAC INJURY; COAGULATION; DOXORUBICIN; MAPK; NF-ΚB; TRANS FAT;

ANIMALS; ANTITHROMBIN III; C-REACTIVE PROTEIN; CARDIOTOXINS; CHEMOKINE CCL2; CREATINE KINASE; DIETARY FATS; DOXORUBICIN; FIBRINOGEN; HEART DISEASES; INTERLEUKIN-10; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TRANS FATTY ACIDS; TRANSCRIPTION FACTOR RELA; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84885418610     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.12257     Document Type: Article

References (29)

1. Anderson EK, Hill AA, Hasty AH. 2012. Stearic acid accumulation in macrophages induces toll-like receptor 4/2-independent inflammation leading to endoplasmic reticulum stress-mediated apoptosis. Arterioscler Thromb Vasc Biol 32:1687-95.
2. Asakawa H, Tokunaga K, Kawakami F. 2000. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. J Diabetes Complications 14:121-6.
3. Calder PC. 2009. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 91:791-5.
4. Chen CL, Tetri LH, Neuschwander-Tetri BA, Huang SS, Huang JS. 2011. A mechanism by which dietary trans fats cause atherosclerosis. J Nutr Biochem 22:649-55.
5. Coffey CS, Asselbergs FW, Hebert PR, Hillege HL, Li Q, Moore JH, van Gilst WH. 2011. The association of the metabolic syndrome with PAI-1 and t-PA levels. Cardiol Res Pract 2011:541467.
6. Doehner W, Landmesser U. 2011. Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Semin Nephrol 31:433-40.
7. Estadella D, da Penha Oller do Nascimento CM, Oyama LM, Ribeiro EB, Dâmaso AR, de Piano A. 2013. Lipotoxicity: effects of dietary saturated and transfatty acids. Mediators Inflamm 2013:137579.
8. Harvey KA, Arnold T, Rasool T, Antalis C, Miller SJ, Siddiqui RA. 2008. Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br J Nutr 99:723-31.
9. Iwata NG, Pham M, Rizzo NO, Cheng AM, Maloney E, Kim F. 2011. Trans fatty acids induce vascular inflammation and reduce vascular nitric oxide production in endothelial cells. PLoS One 6:e29600.
10. Kalivendi SV, Konorev EA, Cunningham S, Vanamala SK, Kaji EH, Joseph J, Kalyanaraman B. 2005. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem J 389:527-39.
11. Kang YJ, Zhou ZX, Wang GW, Buridi A, Klein JB. 2000. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J Biol Chem 275:13690-8.
12. Li SEM, Yu B. 2008. Adriamycin induces myocardium apoptosis through activation of nuclear factor kappaB in rat. Mol Biol Rep 35:489-94.
13. Liu WH, Lin CC, Wang ZH, Mong MC, Yin MC. 2010. Effects of protocatechuic acid on trans fat induced hepatic steatosis in mice. J Agric Food Chem 58:10247-52.
14. Lowry OH, Rosebrough NJ, Farr AL. 1951. Protein determination with the Folin phenol reagent. J Biol Chem 193:265-75.
15. Martinovic I, Abegunewardene N, Seul M, Vosseler M, Horstick G, Buerke M, Darius H, Lindemann S. 2005. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circulation J 69:1484-9.
16. Micha R, Mozaffarian D. 2009. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 5:335-44.
17. Morris PG, Chen C, Steingart R, Fleisher M, Lin N, Moy B, Come S, Sugarman S, Abbruzzi A, Lehman R, Patil S, Dickler M, McArthur HL, Winer E, Norton L, Hudis CA, Dang CT. 2011. Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib. Clin Cancer Res 17:3490-9.
18. Mozaffarian D, Aro A, Willett WC. 2009. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 63:5-21.
19. Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. 2012. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52:1213-25.
20. Privratsky JR, Wold LE, Sowers JR, Quinn MT, Ren J. 2003. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 42:206-12.
21. Richard C, Ghibu S, Delemasure-Chalumeau S, Guilland JC, Des Rosiers C, Zeller M, Cottin Y, Rochette L, Vergely C. 2011. Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation. J Pharmacol Exp Ther 339:807-14.
22. Sanders TA, Oakley FR, Crook D, Cooper JA, Miller GJ. 2003. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men. Br J Nutr 89:767-76.
23. Swystun LL, Mukherjee S, Liaw PC. 2011. Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus. J Thromb Haemost 9:2313-21.
24. Szasz T, Thompson JM, Watts SW. 2008. A comparison of reactive oxygen species metabolism in the rat aorta and vena cava: focus on xanthine oxidase. Am J Physiol Heart Circ Physiol 295:H1341-50.
25. Teng LL, Shao L, Zhao YT, Yu X, Zhang DF, Zhang H. 2010. The beneficial effect of n-3 polyunsaturated fatty acids on doxorubicin-induced chronic heart failure in rats. J Int Med Res 38:940-8.
26. Trivedi PP, Kushwaha S, Tripathi DN, Jena GB. 2011. Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat. Cardiovasc Toxicol 11:215-25.
27. Urano T, Ihara H, Suzuki Y, Takada Y, Takada A. 2000. Coagulation associated enhancement of fibrinolytic activity via a neutralization of PAI-1 activity. Semin Thromb Hemostasis 26:39-42.
28. Vaughan DE. 2005. PAI-1 and atherothrombosis. J Thromb Haemost 3:1879-83.
29. Yamamoto Y, Hoshino Y, Ito T, Nariai T, Mohri T, Obana M, Hayata N, Uozumi Y, Maeda M, Fujio Y, Azuma J. 2008. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes. Cardiovasc Res 79:89-96.